Nara Organics

The company's business model is direct-to-consumer, selling its products through its website, with plans for retail expansion. Revenue is generated from the sale of its infant formula, which is offered via single purchase or a subscription model. Nara Organics has successfully raised significant venture capital, securing a total of $32 million from investors including AlleyCorp, Torch Capital, and Corazon Ventures, with an $18.9 million Series A round in October 2024.

Nara Organics' flagship product is a USDA-certified organic, whole milk-based infant formula for babies aged 0-12 months. A key differentiator is its use of whole milk, which provides naturally occurring Milk Fat Globule Membrane (MFGM), as opposed to the skim milk base used in many competing formulas. The formula contains no palm oil, soy, or corn syrup solids. It is developed in the U.S. and manufactured in Germany, adhering to both U.S. FDA and European safety standards, and has undergone over 2,000 safety and quality tests. The product also includes EU-levels of DHA for brain and eye development, as well as prebiotics to support gut health. The company has received the Clean Label Purity Award, certifying it has been tested for contaminants like heavy metals. Prior to launching its physical product, the company built a community of over one million parents through its Nara Baby + Mom Tracker app.